Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation of Gut Mucosal Microbiome With Anti‐Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease

8 Aug 2019

Abstract excerpt

OBJECTIVES: Crohn disease (CD) is a chronic relapsing condition possibly caused by a dysbiotic microbiome. Approximately 30% to 60% of patients with CD have anti-Saccharomyces cerevisiae antibody (ASCA), but any association with gut microbiota is unexplored. We hypothesized that ASCA positivity would predict a signature microbial status and clinical phenotype. METHODS: Ileocolonic mucosal biopsies were obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Inflammatory Bowel Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31764438
DOI: 10.1097/mpg.0000000000002461

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation of Gut Mucosal Microbiome With Anti‐Saccharomyces cerevisiae Antibody Status in Pediatric Crohn DiseasePMID 31764438Read ↗

Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.Semantic proximity Read ↗

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.Semantic proximity Read ↗

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiomeSemantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.Semantic proximity Read ↗

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?Semantic proximity Read ↗

Deciphering salivary microbiome signature in Crohn’s disease patients with different factors contributing to dysbiosisSemantic proximity Read ↗

Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.Semantic proximity Read ↗

Diagnostic utility and phenotype correlation of serum ASCA and ANCA in pediatric inflammatory bowel diseaseSemantic proximity Read ↗

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.